PDK4 and metabolic dysfunction-associated steatohepatitis: PDK4, which is an inhibitor of the pyruvate dehydrogenase complex [35], is higher expressed on the protein and gene level in NASH liver samples, and PDK4 deficiency in mice leads to reduced steatosis [36].